Health Canada inspection
Daiichi Sankyo Chemical Pharma Co., Ltd.: Health Canada inspection of Mar 18, 2022
Health Canada · GMP · rating C
Key facts
| Establishment | Daiichi Sankyo Chemical Pharma Co., Ltd. |
|---|---|
| City | Oaza Akaiwa, Chiyoda-machi, Oura-gun, Gunma |
| Country | Japan |
| Program | GMP |
| Start date | Mar 16, 2022 |
| End date | Mar 18, 2022 |
| Rating | C |
| Rating description | Compliant |
| Licence number | Not applicable |
At a glance
- 1–9 Inspections of this establishment
- No Currently licensed
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Health Canada inspections
Health Canada inspects establishments that conduct licensable activities with drugs, including good manufacturing practices (GMP) and pharmacovigilance (GVP) inspections. Clinical trial (GCP) inspections, which name individuals, are not published here.